Reduction of Hyperbilirubinemia With Hypericum Extract (St. John's Wort) in a Patient With Crigler-Najjar Syndrome Type II

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.12869
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

St John's Wort (Hypericum Perforatum): Drug Interactions and Clinical Outcomes

British Journal of Clinical Pharmacology
Pharmacology
2002English

Identification of a Novel Deletion in UDP-glucuronosyltransferase Gene in a Patient With Crigler–Najjar Syndrome Type I

Blood Cells, Molecules, and Diseases
Molecular MedicineHematologyMolecular BiologyCell Biology
2009English

A Novel Pathogenic UGT1A1 Variant in a Sudanese Child With Type I Crigler-Najjar Syndrome

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2018English

The First Case of Crigler-Najjar Syndrome Type-1 in Japan

Acta Hepatologica Japonica
Hepatology
1980English

St John's Wort for Depression

BMJ
1996English

Two Unrelated Patients With Rare Crigler-Najjar Syndrome Type I: Two Novel Mutations and a Patient With Loss of Heterozygosity of UGT1A1 Gene

Journal of Zhejiang University: Science B
GeneticsPharmacologyMolecular BiologyBiochemistryVeterinaryMedicineToxicologyPharmaceutics
2014English

Acute Treatment of Moderate to Severe Depression With Hypericum Extract WS 5570 (St John's Wort): Randomised Controlled Double Blind Non-Inferiority Trial Versus Paroxetine

BMJ
2005English

UGT1a1 Gene Mutations in a Tibetan Patient With Crigler-Najjar SyndromeType II - Case Report and Literature Review

Current Trends in Clinical & Medical Imaging
2018English

Nutrition and Health Info Sheet: St. John's Wort

2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy